Doctor-written aesthetic medicine guide · Johor Bahru
Melasma can return because treatment lightens visible pigment without permanently removing the skin’s tendency to produce it. Light, hormones and inflammation continue after a successful treatment phase.
Introduction
Melasma can return because treatment lightens visible pigment without permanently removing the skin’s tendency to produce it. Light, hormones and inflammation continue after a successful treatment phase. Patients often arrive with the name of a device, injectable or package already in mind. My first responsibility is to establish whether that treatment matches the diagnosis, tissue pattern and degree of change the patient wants.
This guide explains why melasma comes back in the context of doctor-led care at Dr Plus Aesthetic Clinic in Johor Bahru. It is designed to help you ask better questions, understand realistic limits and recognise when a concern needs a different assessment or urgent attention. It does not replace examination and does not promise a particular result.
Key takeaways
| Clinical question | Practical answer |
|---|---|
| Core point | Melasma can return because treatment lightens visible pigment without permanently removing the skin’s tendency to produce it. Light, hormones and inflammation continue after a successful treatment phase. |
| How it works | Melanocytes remain responsive after pigment fades. Stopping maintenance abruptly, inconsistent sunscreen, new hormonal exposure or an irritating procedure can restart pigment production. Recurrence does not automatically mean the original treatment was useless. |
| Who may benefit | Patients whose melasma improved and later darkened again or who are planning long-term maintenance. |
| Who needs another pathway | People assuming repeated high-intensity laser is the only response to recurrence. |
| Evidence | Authoritative melasma guidance describes a chronic relapsing condition and warns that procedures can cause PIH or worsen melasma, supporting maintenance rather than repeated escalation. |
| Safety | Prompt review is appropriate for rapid rebound with burning, blistering, sharply uneven lightening or darkening, or a new lesion unlike the original melasma. |

What the concern actually involves
Melanocytes remain responsive after pigment fades. Stopping maintenance abruptly, inconsistent sunscreen, new hormonal exposure or an irritating procedure can restart pigment production. Recurrence does not automatically mean the original treatment was useless. That distinction matters because two people who use the same everyday description may have different causes, depths, proportions or risks. A treatment that is logical for one pattern may be ineffective or unnecessarily risky for another.
The visible feature is only one layer of the decision. Skin colour and reactivity, barrier condition, tissue thickness, facial movement, past inflammation, previous procedures and the patient’s capacity for downtime all influence a medical plan. In Malaysia, regular light exposure and warm weather can also make pigment protection, wound care and comfortable adherence especially important.
Who the discussion is most useful for
Patients whose melasma improved and later darkened again or who are planning long-term maintenance.
Who should not proceed from this article alone
People assuming repeated high-intensity laser is the only response to recurrence.
When the diagnosis is uncertain, the correct decision may be to observe, photograph, investigate or refer rather than start an aesthetic procedure. This is a useful outcome of consultation, not a failed consultation.
Why assessment comes before treatment
A safe consultation converts a broad concern into a defined treatment target. It also checks whether the expected improvement is large enough to justify cost, recovery and risk. The following sequence is a practical framework:
- Define the exact concern in plain language and identify when it began, what changes it and whether it is stable.
- Examine the relevant skin, tissue or facial anatomy rather than diagnosing from a treatment request alone.
- Review medical history, medicines, allergies, pregnancy or breastfeeding where relevant, infections, previous procedures and healing response.
- Separate the desired change from features that the proposed treatment cannot reasonably alter.
- Compare lower-intervention care, staged procedures, referral and no treatment before consent.
- Agree on photographs, review timing, aftercare, warning symptoms and an emergency contact route.
Standardised photographs can improve this discussion. Lighting, angle, expression and camera distance should be consistent because small differences can create the illusion of change. The assessment should also record the exact product or device proposed; category names alone do not tell a patient the material, wavelength, depth, settings or regulatory status.
How the main options differ
There is rarely one best treatment in isolation. The meaningful comparison is between mechanisms, expected scale of change, recovery, evidence and complication pathways. For why melasma comes back, the following distinctions are particularly relevant.
Maintenance care
Use the lowest-burden plan that keeps the condition controlled. The doctor should explain how this option addresses the diagnosed target, what it leaves unchanged and which sign would make the plan inappropriate.
Trigger review
Check light exposure, adherence, hormones and irritation before changing devices. The doctor should explain how this option addresses the diagnosed target, what it leaves unchanged and which sign would make the plan inappropriate.
Treatment cycles
Some medicines require monitored cycles rather than indefinite unsupervised use. The doctor should explain how this option addresses the diagnosed target, what it leaves unchanged and which sign would make the plan inappropriate.
Procedure restraint
Do not chase every fluctuation with more energy treatment. The doctor should explain how this option addresses the diagnosed target, what it leaves unchanged and which sign would make the plan inappropriate.
Choosing no procedure, simplifying skincare, treating an active medical condition or seeking a surgical opinion are all legitimate options. A responsible plan does not force every concern into a device or injection.

What the evidence can and cannot tell us
Authoritative melasma guidance describes a chronic relapsing condition and warns that procedures can cause PIH or worsen melasma, supporting maintenance rather than repeated escalation. This is useful for setting a general direction, but research populations, outcome scales, techniques and follow-up periods do not perfectly reproduce an individual consultation. Published improvement also does not mean every patient improved or that the change was large enough to satisfy every goal.
Evidence links: Source 1 · Source 2 · Source 3 · Source 4 · Source 5
Evidence should be interpreted alongside clinical experience without treating experience as proof. Questions worth asking include whether studies evaluated the same product or device, whether outcomes were independently assessed, how long patients were followed and how complications were collected. Before-and-after images can illustrate a possibility but cannot establish the likelihood of the same result for you.
Potential benefits
When diagnosis, patient selection and technique align, a plan may provide several practical benefits:
- reduces surprise about recurrence
- supports safer long-term care
- avoids unnecessary escalation
- helps distinguish relapse from a complication
Benefits should be translated into observable changes rather than vague claims such as rejuvenation or collagen boost. Agree on what will be photographed or measured, the expected biological timeline and the point at which further treatment would add too little value.
Limitations and realistic expectations
The most important limitations for this topic include:
- maintenance cannot eliminate every trigger
- response varies seasonally
- medicines have limits
- some recurrence is expected
Results vary even when the same protocol is used. Tissue biology, starting severity, light exposure, inflammation, muscle activity, healing and adherence all matter. Improvement may be partial, temporary or require maintenance. A non-surgical treatment should not be presented as equivalent to surgery, and a skin-quality treatment should not be presented as a structural lift.
It is also possible to create a technically visible change that does not improve overall proportion. For that reason, Dr Kenneth assesses the face or skin as a whole and may recommend a smaller first stage, a different sequence or no treatment.
Risks, side effects and suitability
Common temporary effects and uncommon complications must both be discussed. The level and type of risk depend on whether the treatment uses light, heat, needles, chemicals, an implanted material or a combination. General possibilities include:
- temporary redness, swelling, tenderness or bruising
- infection or delayed healing
- an unwanted cosmetic result or asymmetry
- the need to change or stop the plan after clinical review
Suitability may change with active infection, uncontrolled dermatitis, recent procedures, a history of poor healing or pigment alteration, medicines that affect bleeding or immune response, implanted devices, pregnancy or breastfeeding where treatment is deferred, and expectations that exceed the treatment’s capability. These are discussion points rather than a universal exclusion list.
Prompt review is appropriate for rapid rebound with burning, blistering, sharply uneven lightening or darkening, or a new lesion unlike the original melasma.
Do not attempt to diagnose or treat a serious complication through social media messages. Use the clinic’s emergency instructions or attend appropriate emergency medical care. Early assessment matters because some vascular, visual, neurological, infectious or thermal complications are time-sensitive.
Preparation, recovery and aftercare
Preparation should be specific to the proposed treatment. Generic rules can conflict with medical needs, so do not stop medicines or apply unprescribed products simply because another patient did so.
- Keep the area free from active infection, open wounds and uncontrolled irritation; tell the clinic promptly if this changes.
- Do not stop prescribed medicines on your own. Provide the complete list so the doctor can advise whether timing or technique should change.
- Avoid introducing harsh new skincare immediately before treatment. A stable barrier makes the response easier to interpret.
- Plan around the likely swelling, bruising, redness, peeling or activity restrictions described for the selected procedure.
- Use the written aftercare for your procedure, protect treated skin from sun and attend the planned review before escalating treatment.
Topic-specific aftercare priorities
- continue light protection after improvement
- follow the maintenance schedule
- avoid unplanned product changes
- document recurrence patterns
- review before repeating a procedure
Recovery should trend toward improvement. A review is appropriate when pain, swelling, redness, colour change, asymmetry or wound symptoms are worsening instead of settling, or when the recovery pattern differs from what was explained. Keep photographs and exact product or device records if you seek assessment elsewhere.

How this article supports your treatment pathway
This cluster guide answers a focused patient question. The main Melasma Treatment Johor Bahru page explains the broader service, suitability and consultation pathway in Johor Bahru. Linking the educational topic to its primary treatment page helps patients move from general research to a clinically relevant assessment without creating competing pages for the same search intent.
If you are comparing several treatments, begin with the concern rather than the product. Ask which layer is responsible, what each method can realistically change, whether staged care would be easier to judge, and which result or side effect would make the plan stop. A coordinated pathway reduces duplicated treatment and makes follow-up more meaningful.
Questions to take to your consultation
A useful consultation should make the decision clearer even if it ends without a procedure. Consider asking:
- What diagnosis or anatomical feature are we treating?
- Why does this option fit my skin type, tissue pattern and medical history?
- What exact product, device, wavelength, depth or technique will be used?
- What improvement is realistic, and what will remain unchanged?
- What are the common effects and the uncommon but serious complications?
- What is the expected recovery pattern and emergency contact route?
- What evidence supports this plan, and are there reasonable alternatives?
- When will we review, and what criteria decide whether another stage is worthwhile?
Consent is an ongoing conversation, not just a signature. You can pause, ask for clarification or decide that the expected benefit does not justify the intervention.
Frequently asked questions
What is the short answer about why melasma comes back?
Melasma can return because treatment lightens visible pigment without permanently removing the skin’s tendency to produce it. Light, hormones and inflammation continue after a successful treatment phase. The useful next step is a diagnosis or anatomical assessment rather than choosing treatment from a photograph or package name.
Can an online article confirm that I am suitable?
No. An article can explain patterns, options and warning signs, but it cannot examine skin, palpate tissue, review medical history or confirm the exact device, product and settings that would be appropriate.
How many sessions or treatments will I need?
There is no responsible universal number. The starting condition, target, response, recovery and evidence for the selected treatment determine whether another stage is worthwhile.
Will the result be permanent?
Usually not. some recurrence is expected. Aging, light exposure, inflammation, muscle activity and other biological factors can continue after treatment.
Is the strongest setting or largest amount better?
No. More treatment can increase inflammation, swelling, pigment change, asymmetry or other complications without producing a proportionate benefit. Conservative staging allows response to guide the next decision.
Can treatments be combined on the same day?
Sometimes, but combination should have a clear reason. Each added procedure changes inflammation, recovery and interpretation of side effects. A staged plan is often easier to assess and safer to adjust.
What should I tell Dr Kenneth before treatment?
Share medicines, supplements, allergies, pregnancy or breastfeeding status where relevant, previous procedures, cold sores, infections, scarring or pigment history, implanted devices and any unusual response to injections or energy treatments.
What is normal after a procedure?
Expected recovery depends on the exact treatment. Mild redness, swelling, tenderness or bruising may occur, but the clinic should explain the anticipated pattern and provide a route for urgent review.
Which warning signs should not wait?
Prompt review is appropriate for rapid rebound with burning, blistering, sharply uneven lightening or darkening, or a new lesion unlike the original melasma.
What should I bring to a consultation in Johor Bahru?
Bring a list of medicines and previous treatments, product or device records if available, clear photographs of earlier reactions, your usual skincare and the dates of any upcoming travel or important events.
Conclusion
Melasma can return because treatment lightens visible pigment without permanently removing the skin’s tendency to produce it. Light, hormones and inflammation continue after a successful treatment phase. The safest path is to identify the diagnosis or anatomical target, compare methods honestly and use the least intervention that can reasonably meet the goal. Authoritative melasma guidance describes a chronic relapsing condition and warns that procedures can cause PIH or worsen melasma, supporting maintenance rather than repeated escalation. Individual suitability and results still require examination.
Dr Kenneth Lee’s approach is doctor-led, measured and personal: clarify what can change, protect what is healthy, explain uncertainty and review the response before adding treatment.
Start with a doctor-led assessment
Bring your concern, treatment history, current skincare and questions. Dr Kenneth will explain suitable options, limitations and next steps without promising a result.
Arrange a consultationReferences
- DermNet: Melasma
- DermNet: Postinflammatory hyperpigmentation
- DermNet: Laser treatment
- American Academy of Dermatology: Skin conditions treated with lasers
- American Academy of Dermatology: Chemical peel FAQs
Medical information notice: This article provides general education and does not diagnose a condition or replace an in-person medical assessment. Treatment suitability, benefits, risks, alternatives and recovery vary between individuals.